{"id":1076,"date":"2017-08-01T06:35:43","date_gmt":"2017-08-01T06:35:43","guid":{"rendered":"https:\/\/xavant.com\/?p=1076"},"modified":"2018-10-15T16:38:32","modified_gmt":"2018-10-15T14:38:32","slug":"stimpod-nms460-receives-fda-clearance-usa","status":"publish","type":"post","link":"https:\/\/xavant.com\/de\/stimpod-nms460-receives-fda-clearance-usa\/","title":{"rendered":"Stimpod NMS460 erh\u00e4lt die FDA-Zulassung (USA)"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><div class=\"vc_row wpb_row vc_row-fluid\"><div class=\"wpb_column vc_column_container vc_col-sm-12\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\">\n\t<div class=\"wpb_text_column wpb_content_element \" >\n\t\t<div class=\"wpb_wrapper\">\n\t\t\t<p><strong>Pretoria, South Africa<\/strong>\u00a0\u2013 Xavant Technology (Pty) Ltd today announced that the U.S. Food and Drug Administration (FDA) cleared their Stimpod NMS460. With the U.S. patent awarded on proprietary hybrid pulsed radio frequency (PRF) waveform, this non-invasive neuromodulation device is focused on the symptomatic relief and management of chronic intractable pain, as well as an adjunctive treatment in the management of post-surgical pain, post traumatic acute pain problems, and an adjunct for pain control due to rehabilitation.<\/p>\n<p>The need for this device is profound. More than 100 million Americans report that they have a problem with pain.<a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftn1\" name=\"_ftnref1\">[1]<\/a>\u00a0\u00a0Chronic pain is characterized by neuroplastic changes that cause sensitization of the nervous system. These changes result in anatomical and physiological changes that affect neurological function, which causes long-term potentiation and gene expression changes that then allow the pain to continue with or without further peripheral input, and a lower pain threshold; this dysfunction then also accounts for the epiphenomena associated with the disease, including emotional, memory, and motor changes, which then becomes the illness of chronic pain.<a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftn2\" name=\"_ftnref2\">[2]<\/a><\/p>\n<p>Treatment of chronic pain in the United States is estimated to cost $600 billion annually.<a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftn3\" name=\"_ftnref3\">[3]<\/a>\u00a0The current standard of care for chronic pain includes drug cocktails such as Corticosteroids, Opiate pain relievers, injections, and beyond combined with treatments like physical therapy and counseling. Treatments can come with various short-term and long-term side effects.<\/p>\n<p>The Stimpod NMS460, however, will greatly impact the industry as a non-invasive, non-drug solution with zero side effects and a fast onset of effect at a fraction of the cost of comparable treatments. The device applies its patented PRF waveform to the affected area transcutaneously. This waveform creates electromagnetic effects similar to invasive pulsed radio frequency treatments, and several case studies have shown instant and dramatic relief of chronic intractable pain. The Stimpod NMS460 also incorporates the nerve-locating technology which features a nerve mapping probe that enables practitioners to locate nerves and evaluate the treatment progress of damaged nerves. Bell Medical has been selected as the master distributor for both the U.S. and Canada.<\/p>\n<p>\u201cWe are thrilled at the news that our revolutionary device can now be used in the U.S.,\u201d said Corlius Birkill, CEO of Xavant Technology (Pty) Ltd. \u201cThis ground-breaking technology has the ability to help tens if not hundreds of millions of people just in the U.S. as a valuable treatment asset for neurologists, chiropractors, acupuncturists, physical therapists, physiatrists, and medical pain practitioners.\u201d<\/p>\n<p><a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftnref1\" name=\"_ftn1\">[1]<\/a>\u00a0Gaskin, Darrell J., and Patrick Richard. \u201cThe Economic Costs of Pain in the United States.\u201d\u00a0<em>The Journal of Pain: Official Journal of the American Pain Society<\/em>\u00a0(2012): 715-24. Web. 21 June 2017.<\/p>\n<p><a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftnref2\" name=\"_ftn2\">[2]<\/a>\u00a0American Academy Of Pain Medicine.\u00a0<em>Neuropathic Pain Recognized as a Disease<\/em>. N.p.: American Medical Association, 27 Sept. 2016. PDF.\u00a0<a href=\"https:\/\/assets.ama-assn.org\/sub\/meeting\/documents\/i16-resolution-912.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/assets.ama-assn.org\/sub\/meeting\/documents\/i16-resolution-912.pdf<\/a><\/p>\n<p><a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftnref3\" name=\"_ftn3\">[3]<\/a>\u00a0Gaskin, Darrell J., and Patrick Richard. \u201cThe Economic Costs of Pain in the United States.\u201d\u00a0<em>The Journal of Pain: Official Journal of the American Pain Society<\/em>\u00a0(2012): 715-24. Web. 21 June 2017.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Pretoria, S\u00fcdafrika - Xavant Technology (Pty) Ltd gab heute bekannt, dass die US-amerikanische Food and Drug Administration (FDA) ihr Stimpod NMS460 zugelassen hat. Dieses nicht-invasive Neuromodulationsger\u00e4t, f\u00fcr das ein US-Patent auf eine propriet\u00e4re hybride gepulste Radiofrequenz (PRF)-Wellenform erteilt wurde, konzentriert sich auf die symptomatische Linderung und das Management chronischer hartn\u00e4ckiger Schmerzen sowie...<\/p>","protected":false},"author":2,"featured_media":1077,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1076","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-7","description-off"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Stimpod NMS460 Receives FDA Clearance (USA) | Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xavant.com\/de\/stimpod-nms460-receives-fda-clearance-usa\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stimpod NMS460 Receives FDA Clearance (USA) | Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xavant.com\/de\/stimpod-nms460-receives-fda-clearance-usa\/\" \/>\n<meta property=\"og:site_name\" content=\"Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/XavantTechnology\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-08-01T06:35:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-15T14:38:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"314\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Xavant Technology\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@XavantTech\" \/>\n<meta name=\"twitter:site\" content=\"@XavantTech\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Xavant Technology\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\"},\"author\":{\"name\":\"Xavant Technology\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#\\\/schema\\\/person\\\/c8384e46abaf5f32420beb9c3d237ac9\"},\"headline\":\"Stimpod NMS460 Receives FDA Clearance (USA)\",\"datePublished\":\"2017-08-01T06:35:43+00:00\",\"dateModified\":\"2018-10-15T14:38:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\"},\"wordCount\":512,\"publisher\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/fda-cleared_news.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\",\"url\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\",\"name\":\"Stimpod NMS460 Receives FDA Clearance (USA) | Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/fda-cleared_news.jpg\",\"datePublished\":\"2017-08-01T06:35:43+00:00\",\"dateModified\":\"2018-10-15T14:38:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/fda-cleared_news.jpg\",\"contentUrl\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/fda-cleared_news.jpg\",\"width\":400,\"height\":314},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/xavant.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stimpod NMS460 Receives FDA Clearance (USA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#website\",\"url\":\"https:\\\/\\\/xavant.com\\\/\",\"name\":\"Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping\",\"description\":\"Developers of Quantitative TOF Monitors (NMT Monitors), Nerve Mapping and Locating devices.\",\"publisher\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/xavant.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#organization\",\"name\":\"Xavant Technology\",\"url\":\"https:\\\/\\\/xavant.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/10\\\/Xavant-Logo-Original-Colours.png\",\"contentUrl\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/10\\\/Xavant-Logo-Original-Colours.png\",\"width\":1636,\"height\":306,\"caption\":\"Xavant Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/XavantTechnology\\\/\",\"https:\\\/\\\/x.com\\\/XavantTech\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/xavant-technology\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#\\\/schema\\\/person\\\/c8384e46abaf5f32420beb9c3d237ac9\",\"name\":\"Xavant Technology\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g\",\"caption\":\"Xavant Technology\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stimpod NMS460 erh\u00e4lt FDA-Zulassung (USA) | Xavant Technology | TOF-Monitore, NMT-\u00dcberwachung, Nerve Mapping","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xavant.com\/de\/stimpod-nms460-receives-fda-clearance-usa\/","og_locale":"de_DE","og_type":"article","og_title":"Stimpod NMS460 Receives FDA Clearance (USA) | Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping","og_url":"https:\/\/xavant.com\/de\/stimpod-nms460-receives-fda-clearance-usa\/","og_site_name":"Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping","article_publisher":"https:\/\/www.facebook.com\/XavantTechnology\/","article_published_time":"2017-08-01T06:35:43+00:00","article_modified_time":"2018-10-15T14:38:32+00:00","og_image":[{"width":400,"height":314,"url":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","type":"image\/jpeg"}],"author":"Xavant Technology","twitter_card":"summary_large_image","twitter_creator":"@XavantTech","twitter_site":"@XavantTech","twitter_misc":{"Verfasst von":"Xavant Technology","Gesch\u00e4tzte Lesezeit":"3\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#article","isPartOf":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/"},"author":{"name":"Xavant Technology","@id":"https:\/\/xavant.com\/#\/schema\/person\/c8384e46abaf5f32420beb9c3d237ac9"},"headline":"Stimpod NMS460 Receives FDA Clearance (USA)","datePublished":"2017-08-01T06:35:43+00:00","dateModified":"2018-10-15T14:38:32+00:00","mainEntityOfPage":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/"},"wordCount":512,"publisher":{"@id":"https:\/\/xavant.com\/#organization"},"image":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","articleSection":["News"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/","url":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/","name":"Stimpod NMS460 erh\u00e4lt FDA-Zulassung (USA) | Xavant Technology | TOF-Monitore, NMT-\u00dcberwachung, Nerve Mapping","isPartOf":{"@id":"https:\/\/xavant.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#primaryimage"},"image":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","datePublished":"2017-08-01T06:35:43+00:00","dateModified":"2018-10-15T14:38:32+00:00","breadcrumb":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#primaryimage","url":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","contentUrl":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","width":400,"height":314},{"@type":"BreadcrumbList","@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/xavant.com\/"},{"@type":"ListItem","position":2,"name":"Stimpod NMS460 Receives FDA Clearance (USA)"}]},{"@type":"WebSite","@id":"https:\/\/xavant.com\/#website","url":"https:\/\/xavant.com\/","name":"Xavant Technology | TOF-Monitore, NMT-\u00dcberwachung, Nervenkartierung","description":"Entwickler von quantitativen TOF-Monitoren (NMT-Monitoren), Nervenkartierungs- und Lokalisierungsger\u00e4ten.","publisher":{"@id":"https:\/\/xavant.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xavant.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/xavant.com\/#organization","name":"Xavant Technologie","url":"https:\/\/xavant.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/xavant.com\/#\/schema\/logo\/image\/","url":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/10\/Xavant-Logo-Original-Colours.png","contentUrl":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/10\/Xavant-Logo-Original-Colours.png","width":1636,"height":306,"caption":"Xavant Technology"},"image":{"@id":"https:\/\/xavant.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/XavantTechnology\/","https:\/\/x.com\/XavantTech","https:\/\/www.linkedin.com\/company\/xavant-technology\/"]},{"@type":"Person","@id":"https:\/\/xavant.com\/#\/schema\/person\/c8384e46abaf5f32420beb9c3d237ac9","name":"Xavant Technologie","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g","caption":"Xavant Technology"}}]}},"_links":{"self":[{"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/posts\/1076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/comments?post=1076"}],"version-history":[{"count":0,"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/posts\/1076\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/media\/1077"}],"wp:attachment":[{"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/media?parent=1076"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/categories?post=1076"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/tags?post=1076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}